NCT06033053

Brief Summary

This is randomized active-sham group controlled between-subject real-time fMRI neurofeedback trial aimed at modulating the ventromedial prefrontal cortex (vmPFC)-amygdala pathway to control subjective anxiety and arousal.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 28, 2023

Completed
4 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 13, 2023

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2025

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

1.3 years

First QC Date

August 28, 2023

Last Update Submit

April 9, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Functional connectivity computed from blood oxygenation level dependent (BOLD) functional magnetic resonance imaging between regions of interest.

    Increased functional connectivity computed from BOLD fMRI over the course of the real-time NF-fMRI training sessions in the neurofeedback group (regions of interest: bilateral amygdala and prefrontal area) but not in the sham group (regions of interest: bilateral motor cortex and primary auditory areas). Functional connectivity strength will be represented by bivariate regression coefficients from a general linear model characterizing the association between their BOLD signal timeseries

    40 minutes

Secondary Outcomes (1)

  • Level of behavioural arousal assessed on NRS from 0 to 10

    10 minutes

Other Outcomes (1)

  • Level of behavioural anxiety assessed on NRS from 0 to 10

    10 minutes

Study Arms (2)

Experimental

EXPERIMENTAL

The experimental group will learn how to modulate the vmPFC-amygdala functional connectivity while being presented with pictures inducing fear.

Device: Real-time fMRI neurofeedback from Turbo Brain voyager (TBV) 3.2

Sham

SHAM COMPARATOR

The sham group will learn how to modulate the functional connectivity of sham ROIs while being presented with pictures inducing fear.

Device: Real-time fMRI neurofeedback from Turbo Brain voyager (TBV) 3.2

Interventions

The two groups will undergo the same paradigm while learning to modulate the vmPFC -amygdala pathway and the sham pathway.

ExperimentalSham

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • age \> 18 years old
  • other genders
  • No past or current psychiatric or neurological or other main disorders.

You may not qualify if:

  • Pregnant, taking oral contraceptives
  • Current use of medications
  • Contraindication to MRI scanning (e.g., metal implants, claustrophobia or other conditions that make them inappropriate for MRI scanning).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Electronic Science and Technology of China

Chengdu, Sichuan, 611731, China

RECRUITING

MeSH Terms

Conditions

Emotional Regulation

Condition Hierarchy (Ancestors)

Self-ControlSocial BehaviorBehavior

Study Officials

  • Benjamin Becker, Ph.D.

    University of Electronic Science and Technology of China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Benjamin Becker, Ph.D.

CONTACT

Stefania Ferraro, Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The recruiter and the person in charge of conducting the experiment will be blind to the experimental condition, as will the participants.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Randomized active-sham group controlled between-subject: Group of healthy individuals will be randomly assigned to the experimental or the sham condition. The experimental group, will learn how to modulate the vmPFC-amygdala functional connectivity, while the sham group will try to modulate the functional connectivity of sham regions not involved in emotion regulation.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

August 28, 2023

First Posted

September 13, 2023

Study Start

September 1, 2023

Primary Completion

December 31, 2024

Study Completion

March 31, 2025

Last Updated

April 11, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations